Case Reports
[Neuropsychic side effects of bromocriptine in Parkinson's disease]
[Article in
French]
Affiliations
- PMID: 3671965
Item in Clipboard
Case Reports
[Neuropsychic side effects of bromocriptine in Parkinson's disease]
[Article in
French]
Rev Neurol (Paris).
1987.
Abstract
The clinical characteristics of psychiatric side effects of bromocriptine in patients with Parkinson's disease were studied in 12 cases. The clinical picture was characterized by hallucinations and delirium. Daily doses of bromocriptine (more than 30 mg daily), not duration of the disease or pretreatment with levodopa or previous psychiatric diseases, appeared to be the most important causal factor.
Similar articles
-
[Bromocriptine as the 1st treatment of Parkinson's disease. Long term results].Rev Neurol (Paris). 1982;138(5):401-8. Rev Neurol (Paris). 1982. PMID: 7146724 French.
-
Psychiatric effects of bromocriptine and lergotrile in Parkinsonian patients.Adv Biochem Psychopharmacol. 1980;23:287-92. Adv Biochem Psychopharmacol. 1980. PMID: 6104908 No abstract available.
-
[Secondary effects of prolonged levodopa therapy in Parkinson's disease].Med Clin (Barc). 1985 Jun 15;85(3):88-91. Med Clin (Barc). 1985. PMID: 4021630 Spanish. No abstract available.
-
Bromocriptine in Parkinson disease.Pharmacol Rev. 1985 Jun;37(2):217-27. Pharmacol Rev. 1985. PMID: 3901046 Review.
-
Neuropsychological and psychiatric side effects in the treatment of Parkinson's disease.Neurology. 1993 Dec;43(12 Suppl 6):S47-52. Neurology. 1993. PMID: 8264912 Review.
Cited by
-
Current status of dopamine agonists in Parkinson's disease management.Drugs. 1993 Sep;46(3):384-393. doi: 10.2165/00003495-199346030-00005. Drugs. 1993. PMID: 7693430 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical